Manufacturing, Recombinant Proteins

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

NSERC Awards Alliance Grant to PlantForm to Enable Commercial-Scale Production of Protein Therapeutics

December 02, 2020

The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.

AGC Biologics Adds Mammalian Production Capacity in Japan

October 11, 2018

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

The Challenge of Disruptive Technologies in Bioprocessing

July 01, 2018

Increasing demand for biologics is driving the need for innovation in bioprocessing.

Amgen to Build Next-Generation Biomanufacturing Plant

April 11, 2018

The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.

Wuxi Biologics to Install Large-Scale Single-Use Bioreactor

March 22, 2018

The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.

Shire, AB Biosciences Enter Autoimmune Disease Agreement

February 02, 2018

Shire will receive exclusive license to develop and commercialize AB Biosciences' pan receptor interacting molecule program for autoimmune and inflammatory diseases.

Industry Adoption of Single-Use Systems Remains Low

February 01, 2018

Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.

Acquity Arc Bio System Improves Bioseparation Analytical Methods

January 31, 2018

The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.

Univercells to Develop Antibody Production Platform with $2.9-Million Grant

January 23, 2018

The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.